Receptor that binds trail

Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S300000, C435S069100, C435S007100, C435S320100, C435S325000, C435S252300, C435S173300, C536S023100, C536S023500

Reexamination Certificate

active

06642358

ABSTRACT:

BACKGROUND OF THE INVENTION
A protein known as TNF-related apoptosis-inducing ligand (TRAIL) is a member of the tumor necrosis factor family of ligands (Wiley et al.,
Immunity,
3:673-682, 1995). TRAIL has demonstrated the ability to induce apoptosis of certain transformed cells, including a number of different types of cancer cells as well as virally infected cells (PCT application WO 97/01633 and Wiley et al., supra).
Identification of receptor protein(s) that bind TRAIL would prove useful in further study of the biological activities of TRAIL. However, prior to the present invention, no receptor for TRAIL had been reported.
SUMMARY OF THE INVENTION
The present invention is directed to a novel protein designated TRAIL receptor (TRAIL-R), which binds to a protein known as TNF-related apoptosis-inducing ligand (TRAIL). DNA encoding TRAIL-R, and expression vectors comprising such DNA, are provided. A method for producing TRAIL-R polypeptides comprises culturing host cells transformed with a recombinant expression vector encoding TRAIL-R, under conditions that promote expression of TRAIL-R, then recovering the expressed TRAIL-R polypeptides from the culture. Antibodies that are immunoreactive with TRAIL-R are also provided.


REFERENCES:
patent: 5763223 (1998-06-01), Wiley et al.
patent: 6313269 (2001-11-01), Deen et al.
patent: 6342369 (2002-01-01), Ashkenazi
patent: 6417328 (2002-07-01), Alnemri
patent: 2002/0072091 (2002-06-01), Ni et al.
patent: 870827 (1998-10-01), None
patent: WO 98/32856 (1998-07-01), None
patent: WO 98/41629 (1998-09-01), None
patent: WO 98/46643 (1998-10-01), None
patent: WO 98/51793 (1998-11-01), None
patent: WO 99/02653 (1999-01-01), None
patent: WO 99/09165 (1999-02-01), None
patent: WO 99/12963 (1999-03-01), None
U.S. patent application Ser. No. 60/041,230, Deen et al., filed Mar. 14, 1997.
U.S. patent application Ser. No. 08/853,684, Deen et al., filed May 9, 1997.
U.S. patent application Ser. No. 08/916,625, Deen et al., filed Aug. 22, 1997.
U.S. patent application Ser. No. 60/040,846, Ni et al., filed Mar. 17, 1997.
Berger et al., “Guide to Molecular Cloning Techniques, Methods in Enzymology,” Academic Press, Inc., 152:661-663, 1987.
Bowie et al., “Deciphering the Message in Protein Sequences: Tolerance to Amino Acid Substitutions,”Science, 247:1306-1310, 1990.
Cross et al., “Purification of CpG Islands Using a Methylated DNA Binding Column,”Nature Genetics, 6:236-244, 1994.
U.S. patent application Ser. No. 60/054,021, Ni et al., filed Jul. 29, 1997.
U.S. patent application Ser. No. 08/843,652, Holtzman, filed Apr. 16, 1997.
U.S. patent application Ser. No. 08/857,216, Ashkenazi, filed May 15, 1997.
U.S. patent application Ser. No. 09/020,746, Ashkenazi et al., filed Feb. 9, 1998.
U.S. patent application Ser. No. 60/055,906, Alnemri, filed Aug. 15, 1997.
U.S. patent application Ser. No. 60/058,631, Tschopp, filed Sep. 12, 1997.
U.S. patent application Ser. No. 60/084,422, Tschopp et al., filed May 6, 1998.
Database record for Accession No. AA223122, “zr06g05.rl, Stratagene NT2 Neuronal Precursor 937230 Homo Sapiens cDNA Clone 650744 5′ mRNA Sequence”, Submitted by R.K. Wilson Feb. 19, 1997.
George et al., “Current Methods in Sequence Comparison and Analysis,”in Macromolecular Sequencing and Synthesis, Selected Methods and Applications, Edited by David H. Schlesinger, Alan R. Liss, Inc., New York, pp. 127-149, 1988.
MacDonald et al., “H. Sapiens CpG Island DNA Genomic Msel Fragment, Clone 75a7, Reverse Read cpg75a7.rtla,” Locus HS75A7R, databank record for Accession No. Z66083, Oct. 1995.
Pan et al., “The Receptor for the Cytotoxic Ligand TRAIL”,Science276:111, Apr. 4, 1997.
White et al., “Principles of Biochemistry,” 6:155-158, McGraw-Hill, Inc., 1978.
R.K. Wilson, Databank record for GenBank Accession No. AA232440; submitted Feb. 28, 1997; released Mar. 13, 1998.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Receptor that binds trail does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Receptor that binds trail, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor that binds trail will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3166051

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.